Furthermore, to our knowledge as previously unreported findings, apoE ε4 also associated with altered levels of certain previously identified novel risk biomarkers of CAD, inflammation, diabetes and all-cause mortality. The gene discussed is APOE; the disease is coronary artery disorder.